The decline in breast cancer rates among women over age 50 is linked to less use of hormone replacement therapy (HRT), according to Harvard Researchers. In their study of more than 350,000 women, the decline was most significant for cases of estrogen receptor-positive cancer and among affluent, white women who were most likely to have used HRT.
Source: American Journal of Public Health, February 2010Bookmark this page
E-mail this story
Print this post